GRI BIO, INC. WARRANT TO PURCHASE COMMON STOCKWarrant Agreement • December 23rd, 2022 • Vallon Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS CERTIFIES THAT, for value received, FT618 Investments, LLC (the “Holder”), is entitled to subscribe for and purchase from GRI Bio, Inc., a Delaware corporation (the “Company”), the Exercise Shares at the Exercise Price (each subject to adjustment as provided herein).
GLYCOREGIMMUNE, INC. RESTRICTED STOCK PURCHASE AGREEMENT Walter Marc HertzRestricted Stock Purchase Agreement • December 23rd, 2022 • Vallon Pharmaceuticals, Inc. • Pharmaceutical preparations • California
THIS RESTRICTED STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of March 28, 2009 by and between Glycoregimmune, Inc., a Delaware corporation (the “Company”), and W. Marc Hertz, an individual (the “Purchaser”).
STANDARD OFFICE LEASE LA JOLLA SHORES PLAZAOffice Lease • December 23rd, 2022 • Vallon Pharmaceuticals, Inc. • Pharmaceutical preparations
THIS STANDARD OFFICE LEASE (“Lease”) is entered into effective as of March 2, 2018 (“Effective Date”), between LA JOLLA SHORES PLAZA, LLC, a California limited liability company (“Landlord”), and GRI BIO, INC., a Delaware Corporation (“Tenant”). Landlord and Tenant agree as follows:
GRI BIO, INC. NONQUALIFIED STOCK OPTION AGREEMENT Signature PageNonqualified Stock Option Agreement • December 23rd, 2022 • Vallon Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
GRI Bio, Inc., a Delaware corporation (the “Company”), hereby grants to you (the “Optionee”) the following option (the “Option”) to purchase shares of Common Stock, par value $0.01 per share (“Common Stock”), of the Company:
CONSULTING AND SCIENTIFIC ADVISORY BOARD AGREEMENTConsulting Agreement • December 23rd, 2022 • Vallon Pharmaceuticals, Inc. • Pharmaceutical preparations
THIS CONSULTING AGREEMENT effective as of October 31, 2018 (the “Effective Date”), is between GRI Bio, Inc. (the “Company”), and Vipin Kumar Chaturvedi personally or through Vidur Discoveries LLC (the “Consultant”).
STOCK REDEMPTION AGREEMENTStock Redemption Agreement • December 23rd, 2022 • Vallon Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Stock Redemption Agreement (this “Agreement”) is entered into as of the 2nd day of November, 2018 (the “Effective Date”), by and between GRI Bio, Inc., a Delaware corporation located at 2223 Avenida de la Playa, #208, La Jolla, CA 92037 (the “Company”), and Catalent Ontario Limited, an Ontario company, with an office located at 2125 Ambassador Drive, Ontario N9C 3R5, Canada (the “Stockholder”).
GRI BIO, INC. INCENTIVE STOCK OPTION AGREEMENT Signature PageIncentive Stock Option Agreement • December 23rd, 2022 • Vallon Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
GRI Bio, Inc., a Delaware corporation (the “Company”), hereby grants to you (the “Optionee”) the following option (the “Option”) to purchase shares of Common Stock, par value $0.01 per share (“Common Stock”), of the Company:
